PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Omnicell, Inc. (OMCL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS68213N1090
CUSIP68213N109
SectorHealthcare
IndustryHealth Information Services

Highlights

Market Cap$1.28B
EPS-$0.45
PEG Ratio2.28
Revenue (TTM)$1.15B
Gross Profit (TTM)$596.71M
EBITDA (TTM)$37.09M
Year Range$25.69 - $77.14
Target Price$34.50
Short %7.32%
Short Ratio4.20

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Omnicell, Inc.

Popular comparisons: OMCL vs. COST

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Omnicell, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%NovemberDecember2024FebruaryMarchApril
-23.21%
21.14%
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Omnicell, Inc. had a return of -27.11% year-to-date (YTD) and -54.76% in the last 12 months. Over the past 10 years, Omnicell, Inc. had an annualized return of 0.36%, while the S&P 500 had an annualized return of 10.55%, indicating that Omnicell, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-27.11%6.33%
1 month-3.42%-2.81%
6 months-23.21%21.13%
1 year-54.76%24.56%
5 years (annualized)-18.90%11.55%
10 years (annualized)0.36%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-14.51%-18.43%11.39%
2023-20.79%-21.09%-6.13%12.80%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of OMCL is 8, indicating that it is in the bottom 8% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of OMCL is 88
Omnicell, Inc.(OMCL)
The Sharpe Ratio Rank of OMCL is 22Sharpe Ratio Rank
The Sortino Ratio Rank of OMCL is 44Sortino Ratio Rank
The Omega Ratio Rank of OMCL is 55Omega Ratio Rank
The Calmar Ratio Rank of OMCL is 1313Calmar Ratio Rank
The Martin Ratio Rank of OMCL is 1515Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Omnicell, Inc. (OMCL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


OMCL
Sharpe ratio
The chart of Sharpe ratio for OMCL, currently valued at -1.19, compared to the broader market-2.00-1.000.001.002.003.00-1.19
Sortino ratio
The chart of Sortino ratio for OMCL, currently valued at -1.92, compared to the broader market-4.00-2.000.002.004.006.00-1.92
Omega ratio
The chart of Omega ratio for OMCL, currently valued at 0.76, compared to the broader market0.501.001.500.76
Calmar ratio
The chart of Calmar ratio for OMCL, currently valued at -0.65, compared to the broader market0.002.004.006.00-0.65
Martin ratio
The chart of Martin ratio for OMCL, currently valued at -1.26, compared to the broader market0.0010.0020.0030.00-1.26
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.91, compared to the broader market-2.00-1.000.001.002.003.001.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.77, compared to the broader market-4.00-2.000.002.004.006.002.77
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.46, compared to the broader market0.002.004.006.001.46
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market0.0010.0020.0030.007.61

Sharpe Ratio

The current Omnicell, Inc. Sharpe ratio is -1.19. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-1.19
1.91
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Omnicell, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-85.06%
-3.48%
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Omnicell, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Omnicell, Inc. was 86.67%, occurring on Oct 8, 2002. Recovery took 195 trading sessions.

The current Omnicell, Inc. drawdown is 85.06%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.67%Dec 6, 2001211Oct 8, 2002195Jul 18, 2003406
-85.76%Nov 24, 2021567Feb 28, 2024
-77.96%Oct 3, 2007356Mar 3, 20091428Oct 31, 20141784
-72.92%Mar 5, 2004301May 13, 2005489Apr 25, 2007790
-42.27%Sep 7, 20017Sep 21, 200152Dec 5, 200159

Volatility

Volatility Chart

The current Omnicell, Inc. volatility is 10.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
10.46%
3.59%
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Omnicell, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items